Recent Advances on Nitrones Design for Stroke Treatment.

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Stroke Research

Background:

• Stroke remains a leading cause of disability and mortality worldwide.
• Current therapeutic options for stroke are limited, necessitating the development of novel agents.
• Free radical damage and thrombosis are key pathological mechanisms in ischemic stroke.

Purpose of the Study:

• To review and compare novel nitrone compounds for stroke treatment.
• To evaluate the therapeutic potential of tetramethylpyrazine nitrones and quinolylnitrones.
• To assess the efficacy of specific nitrone derivatives in preclinical models of cerebral ischemia.

Main Methods:

• Review of recent advances in tetramethylpyrazine nitrones and quinolylnitrones.
• Functional transformation of natural product ligustrazine to synthesize nitrone derivatives.
• Assessment of thrombolytic activity, free radical scavenging capacity, and neuroprotective effects.
• Evaluation of blood-brain barrier permeability and toxicity profiles.

Main Results:

• (Z)-N-tert-butyl-1-(3,5,6-trimethylpyrazin-2-yl)methanimine oxide (6) demonstrated potent thrombolytic activity and free radical scavenging.
• Compound 6 is nontoxic and permeable across the blood-brain barrier.
• (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (17) exhibited strong neuroprotection and reduced infarct size by scavenging free radicals.

Conclusions:

• Tetramethylpyrazine nitrones and quinolylnitrones represent promising therapeutic agents for stroke.
• These novel nitrones offer multitarget mechanisms including thrombolysis, antioxidant activity, and neuroprotection.
• Further investigation into these compounds could lead to effective treatments for ischemic stroke and cerebral ischemia.